Success Story: NIW Approval for a Graduate Research Assistant in Biochemistry and Cell Biology

Posted by wegreened on June 12, 2026 in NIW, Cell Biology

On April 13^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Biochemistry and Cell Biology (Approval Notice).

General Field: Biochemistry and Cell Biology

Position at the Time of Case Filing: Graduate Research Assistant

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Minnesota

Approval Notice Date: April 13^th, 2026

Processing Time: 14 months, 18 days

Case Summary:

As part of the EB-2 NIW (National Interest Waiver) petition for an M.B.B.S. holder from Bangladesh, our expert team meticulously crafted a compelling petition on the client's behalf. Securing NIW approval without RFE for a graduate research assistant in the field of biochemistry and cell biology working at the intersection of molecular biology, glaucoma therapy, and cell biology is a testament to both the strength of this candidate's research profile and the strategic rigor our firm brings to every petition we take on.

Client Background and Proposed Endeavor

The proposed endeavor is to continue research on identifying molecular pathways involved in the dysfunction of specific eye cells in order to develop targeted treatment methods that address the root causes of glaucoma and improve patient outcomes. With a strong foundation in genetics, pathophysiology, and cell and gene therapy techniques, this researcher brings a highly interdisciplinary perspective to advancing innovative therapeutic strategies against one of the world's leading causes of preventable blindness.

National Significance of the Research

We emphasized that this research carries significant importance and has far-reaching implications for the United States. Glaucoma remains a serious and growing public health challenge, placing considerable strain on the healthcare system and affecting the quality of life of millions of Americans. By identifying the molecular mechanisms behind glaucoma pathogenesis, this body of work directly contributes to the development of more effective treatments that can slow or prevent disease progression, reducing the long-term public health and economic burden of the condition. The proposed endeavor further aligns with national priorities in emerging biotechnology and biomedical innovation, underscoring a meaningful contribution to U.S. scientific leadership and public health interests.

Impressive Credentials and Achievements

To further strengthen the case, we highlighted exceptional credentials:

Publications: An impressive portfolio of 4 peer-reviewed journal articles, 1 first-authored conference abstract, and 1 book chapter.

Citations: The published body of work has been cited 39 times.

Funding: National Institutes of Health

Case Outcome

This researcher's advancing work in glaucoma pathogenesis, molecular biology, and therapeutic development positions the client to make lasting contributions to U.S. public health and biomedical innovation for years to come. We are honored to have supported this journey and extend our sincere best wishes for continued success in both research and career pursuits.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%